Evaluation of Vepoloxamer in Chronic Heart Failure

NCT02596477 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated for administrative reasons not related to safety or efficacy

Conditions

Chronic Heart Failure

Interventions

DRUG: Vepoloxamer
OTHER: 5% dextrose in water

Sponsor

Mast Therapeutics, Inc.